NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Atlas Venture

Atlas Venture

Cambridge, Massachusettsatlasventure.com

Overview

Atlas Venture is an early-stage venture capital firm that creates and invests in biotechnology startup companies in the United States.

Year Founded

1980

AUM

$2.4B

Portfolio Companies

85

Investments

Atlas Venture investments
CompanyDateStageLead
Remix TherapeuticsJun 2026M&ACo-investor
Ethyreal BioJun 2026Series BCo-investor
Galea TherapeuticsApr 2026Private EquityCo-investor
Obsidian TherapeuticsApr 2026Private EquityCo-investor
Vima TherapeuticsMar 2026Series ACo-investor

Key People

Yi Sung Yong

Co-Founder

Maria G. Beconi

Scientific Advisor And Co-Founder Founder CEO. Stealth NewCo

Adam Atlas

Managing Partner

Alexander Bruehl

Until Mar 2008 Senior Partner

David Grayzel

Managing Director

Akshay Vaishnaw

Venture Partner

Jeff Albers

Venture Partner

John Maraganore

Venture Partner

Linda Bain

Venture Partner

Robert Copeland

Venture Partner

Alyssa W.

Partner

André Luiz Maciel

Partner

Anna .

Partner

Bella Z.

Partner

Betty C.

Partner

Bruce Booth

Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersCambridge, Massachusetts
Year Founded1980
AUM$2.4B

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.